NASDAQ: ZSQR
Z Squared Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ZSQR stock forecasts and price targets.

Forecast return on equity

Is ZSQR forecast to generate an efficient return?

Company
-8.42%
Industry
7.46%
Market
141.58%
ZSQR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ZSQR forecast to generate an efficient return on assets?

Company
-7.07%
Industry
-9.71%
ZSQR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ZSQR earnings per share forecast

What is ZSQR's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.17
Avg 2 year Forecast
-$0.18

ZSQR revenue forecast

What is ZSQR's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0-100%
ZSQR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ZSQR revenue growth forecast

How is ZSQR forecast to perform vs Biotechnology companies and vs the US market?

Company
-100%
Industry
34.69%
Market
186.07%
ZSQR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ZSQR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ZSQR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ZSQR$15.03N/AN/A
ALDX$1.57$5.50+250.32%Buy
PMN$10.85$26.50+144.24%Strong Buy
NRXP$2.95$38.25+1,196.61%Strong Buy
CBUS$1.42$9.00+533.80%Buy

Z Squared Stock Forecast FAQ

What is ZSQR's earnings growth forecast for 2026-2027?

(NASDAQ: ZSQR) Z Squared's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 24.74%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,464.73%.

Z Squared's earnings in 2026 is -$11,917,015.On average, 3 Wall Street analysts forecast ZSQR's earnings for 2026 to be -$1,079,107, with the lowest ZSQR earnings forecast at -$1,036,789, and the highest ZSQR earnings forecast at -$1,110,845.

In 2027, ZSQR is forecast to generate -$1,142,583 in earnings, with the lowest earnings forecast at -$1,097,776 and the highest earnings forecast at -$1,176,189.

If you're new to stock investing, here's how to buy Z Squared stock.

What is ZSQR's revenue growth forecast for 2026-2026?

(NASDAQ: ZSQR) Z Squared's forecast annual revenue growth rate of -100% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 186.07%.

Z Squared's revenue in 2026 is $1,363,045.

In 2026, ZSQR is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is ZSQR's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: ZSQR) forecast ROA is -7.07%, which is higher than the forecast US Biotechnology industry average of -9.71%.

What is ZSQR's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: ZSQR) Z Squared's current Earnings Per Share (EPS) is -$2.81. On average, analysts forecast that ZSQR's EPS will be -$0.17 for 2026, with the lowest EPS forecast at -$0.17, and the highest EPS forecast at -$0.18. In 2027, ZSQR's EPS is forecast to hit -$0.18 (min: -$0.18, max: -$0.19).

What is ZSQR's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: ZSQR) forecast ROE is -8.42%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.